[A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES: RUBIDOMYCIN].
D000230:Adenocarcinoma; D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001580:Benzopyrenes; D002286:Carcinoma, Ehrlich Tumor; D003630:Daunorubicin; D007938:Leukemia; D007942:Leukemia, Experimental; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008175:Lung Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D015674:Mammary Neoplasms, Animal; D008325:Mammary Neoplasms, Experimental; D051379:Mice; D009369:Neoplasms; D012106:Research; D012510:Sarcoma 180; D012513:Sarcoma, Experimental; D013302:Streptomyces; D014116:Toxicology
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001580:Benzopyrenes; D003630:Daunorubicin
ADENOCARCINOMA; ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BENZOPYRENES; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; SARCOMA 180, CROCKER; SARCOMA, EXPERIMENTAL; SARCOMA, RETICULUM CELL; STREPTOMYCES; TOXICOLOGIC REPORT
UN NOUVEL ANTIBIOTIQUE 'A PROPRI'ET'ES CYTOSTATIQUES: LA RUBIDOMYCINE.